Literature DB >> 21312006

A comparison of the two evidence-based drug therapies for chronic migraine.

Frederick R Taylor1.   

Abstract

Entities:  

Year:  2011        PMID： 21312006     DOI： 10.1007/s11916-011-0174-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


× No keyword cloud information.
  11 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

Review 2.  Pain: moving from symptom control toward mechanism-specific pharmacologic management.

Authors:  Clifford J Woolf
Journal:  Ann Intern Med       Date:  2004-03-16       Impact factor: 25.391

3.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Authors:  H C Diener; D W Dodick; S K Aurora; C C Turkel; R E DeGryse; R B Lipton; S D Silberstein; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

4.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

Review 5.  Risk factors for headache chronification.

Authors:  Ann I Scher; Lynn A Midgette; Richard B Lipton
Journal:  Headache       Date:  2008-01       Impact factor: 5.887

Review 6.  Clinical course in migraine: conceptualizing migraine transformation.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurology       Date:  2008-09-09       Impact factor: 9.910

7.  Cumulative lifetime migraine incidence in women and men.

Authors:  W F Stewart; C Wood; M L Reed; J Roy; R B Lipton
Journal:  Cephalalgia       Date:  2008-07-15       Impact factor: 6.292

8.  Major life changes before and after the onset of chronic daily headache: a population-based study.

Authors:  A I Scher; W F Stewart; D Buse; D S Krantz; R B Lipton
Journal:  Cephalalgia       Date:  2008-06-28       Impact factor: 6.292

9.  Factors associated with the onset and remission of chronic daily headache in a population-based study.

Authors:  A I Scher; W F Stewart; J A Ricci; R B Lipton
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

10.  Acute migraine therapy: new drugs and new approaches.

Authors:  Teshamae S Monteith; Peter J Goadsby
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598
View more
  1 in total

Review 1.  Botulinum toxins for the prevention of migraine in adults.

Authors:  Clare P Herd; Claire L Tomlinson; Caroline Rick; W J Scotton; Julie Edwards; Natalie Ives; Carl E Clarke; Alexandra Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2018-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.